GGrantIndex
Sort

78,016 grants matching breast cancer

Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers

$1,723,236
Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA

U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$1,722,942
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Molecular Analysis of Breast Cancer Metastasis to the Brain

$1,721,107
Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Adult Stem Cell Therapy For Cardiac Failure

$1,720,861
Neal David Epstein · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

TNF Signaling, Cell Death and Cancer

$1,719,715
Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA

New therapeutic vulnerabilities in breast cancer

$1,718,646
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2023 · CA

New therapeutic vulnerabilities in breast cancer

$1,718,646
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Biological Breast Cancer Classification by qRT-PCR

$1,718,500
Washington University · U01 · FY2005 · CA

Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk

$1,718,471
Ruth E Patterson · University Of California, San Diego · U54 · FY2013 · CA

Genetic Modifiers of Intitiation and Progression of Mammary Cancer

$1,718,012
Kent W Hunter · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Center for 3D Imaging in Cancer Cell Biology

$1,717,953
Denis Wirtz · Johns Hopkins University · U54 · FY2022 · CA

Roles and regulation of p53

$1,717,762
Carol Prives · Columbia Univ New York Morningside · P01 · FY2014 · CA

Bio-Therapies for the Treatment of Cancer

$1,717,588
David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Cellular Mechanisms Of Xenobiotic Transport

$1,717,416
David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

IGF::OT::IGF - TASK ORDER TITLE: CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ; PERIOD OF PERFORMANCE 05/01/2015-04/30/2016

$1,716,924
Thomas Tucker · University Of Kentucky · N01 · FY2015 · CA

Molecular Profiling of Clinical Specimens

$1,716,743
Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

A Follow-up Study for Causes of Illness in Black Women

$1,716,455
Lynn Rosenberg · Boston University Medical Campus · R01 · FY2012 · CA

Environmental regulation of estrogen responsive genes in single living cells

$1,716,423
Joseph Rodriguez · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

A Follow-up Study for Causes of Illness in Black Women

$1,716,010
Lynn Rosenberg · Boston University Medical Campus · R01 · FY2011 · CA

Genetic Modifiers of Initiation and Progression of Mammary Cancer

$1,715,899
Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

PRECISION ANTIBODY-BASED SYNERGISTIC DRUG COMBINATIONS FOR REFRACTORY TRIPLE-NEGATIVE BREAST CANCER

$1,714,270
The General Hospital Corporation · · FY2021 · Defense Health Agency

Washington University Human Tumor Atlas Research Center

$1,714,176
Li Ding · Washington University · U2C · FY2019 · CA

Descriptive Studies and Record Linkage

$1,714,091
William Anderson · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

APOBEC MUTAGENESIS IN BREAST CANCER

$1,713,487
Reuben S Harris · University Of Minnesota · P01 · FY2021 · CA

Precision approaches to refining TP53-associated cancer risk

$1,713,253
Stephen B Gruber · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA